🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Flavia V. Castelino

Harvard University

ORCID: 0000-0001-9862-0299

Also affiliated with Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.721Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry

International Journal of Rheumatic Diseases(2021)10.1111/1756-185x.14253
Top 38%
0.509DataRank
Top 38%11 citations

John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Leland W.K. Chung +12 more

Papers

Driven by 13 papers — median percentile 49. Top paper: “Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease”.

Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease

Arthritis & Rheumatology(2020)10.1002/art.41627
N/A
1.2DataRank · unranked
41 citations

Ning Li, Elizabeth R. Volkmann, Maureen D. Mayes, Dennis Rünger, Binwu Ying +18 more

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30237-x
N/A
1.1DataRank · unranked
48 citations

Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor +27 more

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort

Arthritis Research & Therapy(2021)10.1186/s13075-021-02548-1
N/A
0.637DataRank · unranked
69 citations

Alain Lescoat, Suiyuan Huang, Jessica Gordon, Monique Hinchcliff, Ami A. Shah +15 more

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry

International Journal of Rheumatic Diseases(2021)10.1111/1756-185x.14253
Top 38%
0.509DataRank
Top 38%11 citations

John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Leland W.K. Chung +12 more

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study

Lara D. Veeken(2025)10.1093/rheumatology/keaf062
N/A
0.281DataRank · unranked
4 citations

Richard M. Silver, Virginia Steen, Daniel E. Furst, Flavia V. Castelino, Marcin A. Trojanowski +10 more

Potential of phosphodiesterase 4B inhibitors in the treatment of interstitial lung disease associated with autoimmune diseases

Clinical and Experimental Rheumatology(2024)10.55563/clinexprheumatol/yg6rck
N/A
0.269DataRank · unranked
5 citations

Ayodeji Adegunsoye, Flavia V. Castelino

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation

Clinical and Experimental Rheumatology(2022)10.55563/clinexprheumatol/04rauu
Top 63%
0.212DataRank
Top 63%2 citations

Tracy Frech, Shervin Assassi, Jessica Gordon, Elana J. Bernstein, Virginia Steen +13 more

CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization

Lara D. Veeken(2023)10.1093/rheumatology/kead176
N/A
0.165DataRank · unranked
2 citations

Tracy Frech, Shervin Assassi, Brian Skaug, Jessica Gordon, Kimberly S. Lakin +24 more

Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts

Arthritis & Rheumatology(2025)10.1002/art.43237
N/A
0DataRank · unranked
4 citations

Shervin Assassi, Maureen D. Mayes, Zsuzsanna H. McMahan, Meng Zhang, Julio Charles +28 more

Rituximab for interstitial pneumonia with autoimmune features at two medical centres

Rheumatology Advances in Practice(2021)10.1093/rap/rkab051
N/A
0DataRank · unranked
12 citations

Iazsmin Bauer Ventura, Marcy B. Bolster, Flavia V. Castelino, Amita Sharma, Brent P. Little +5 more

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Clinical Rheumatology(2020)10.1007/s10067-020-05467-9
N/A
0DataRank · unranked
11 citations

John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Flavia V. Castelino +12 more

E-Cigarette Use, Small Airway Fibrosis, and Constrictive Bronchiolitis

NEJM Evidence(2022)10.1056/evidoa2100051
N/A
0DataRank · unranked
37 citations

B. Flashner, David J. Kanarek, Walter J. O’Donnell, Alyssa Soskis, David R. Ziehr +17 more

Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study

The Lancet Rheumatology(2025)10.1016/s2665-9913(24)00403-x
N/A
0DataRank · unranked
20 citations

Dinesh Khanna, Enrico De Lorenzis, Stefano Di Donato, Antonio Carriero, Rebecca L. Ross +15 more